Author:
Ebata Satoshi,Yoshizaki Ayumi,Oba Koji,Kashiwabara Kosuke,Ueda Keiko,Uemura Yukari,Watadani Takeyuki,Fukasawa Takemichi,Miura Shunsuke,Yoshizaki-Ogawa Asako,Asano Yoshihide,Okiyama Naoko,Kodera Masanari,Hasegawa Minoru,Sato Shinichi
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference30 articles.
1. Mortality and survival in systemic sclerosis: systematic review and meta-analysis;Rubio-Rivas;Semin Arthritis Rheum,2014
2. A deeper look at skin scoring in scleroderma — surrogate, outcome, neither or both?;Seibold;Rheumatology (Oxford),2020
3. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006
4. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial;Khanna;Lancet,2016
5. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial;Tashkin;Lancet Respir Med,2016
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献